Pediatrix Medical (MD) Common Equity (2009 - 2026)

Pediatrix Medical has disclosed Common Equity across 18 years of filings, most recently posting $878.6 million for Q1 2026.

• In Q1 2026, Common Equity rose 11.33% year-over-year to $878.6 million; the TTM figure through Mar 2026 stood at $878.6 million (up 11.33% YoY), while the FY2025 annual figure was $865.9 million, up 13.19% from the prior year.
• Common Equity advanced to $878.6 million in Q1 2026, from $865.9 million in the prior quarter.
• Over the last five years, Common Equity for MD reached as high as $968.0 million in Q3 2023 and fell as low as $706.5 million in Q2 2024.
• The 5-year median for Common Equity is $858.7 million (2022), against an average of $850.6 million.
• Annual changes were most pronounced in 2024 — Common Equity slipped 25.03% — and 2025, when it climbed 21.59%.
• A 5-year view of Common Equity shows it stood at $891.6 million in 2022, then slipped by 4.77% to $849.1 million in 2023, then slipped by 9.91% to $764.9 million in 2024, then climbed by 13.19% to $865.9 million in 2025, then climbed by 1.47% to $878.6 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $878.6 million, $865.9 million, and $890.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.